First human tests: new Drug's safety checked in healthy people
NCT ID NCT05732194
Summary
This early-stage study aimed to understand the safety and how the body processes a new drug called ITI-333. It involved 32 healthy volunteers who received either the drug or a placebo daily for two weeks. The main goals were to check for side effects and measure how the drug moves through and stays in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Site 1
Miami, Florida, 33014-3616, United States
Conditions
Explore the condition pages connected to this study.